Definitive Healthcare Corp Stock Analysis

DH Stock  USD 2.97  0.16  5.69%   
Definitive Healthcare Corp is undervalued with Real Value of 3.43 and Target Price of 5.25. The main objective of Definitive Healthcare stock analysis is to determine its intrinsic value, which is an estimate of what Definitive Healthcare Corp is worth, separate from its market price. There are two main types of Definitive Healthcare's stock analysis: fundamental analysis and technical analysis.
The Definitive Healthcare stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Definitive Healthcare's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Definitive Healthcare Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Definitive Stock Analysis Notes

About 95.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.71. Some equities with similar Price to Book (P/B) outperform the market in the long run. Definitive Healthcare has Price/Earnings To Growth (PEG) ratio of 1.03. The entity recorded a loss per share of 3.54. The firm had not issued any dividends in recent years. Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts. Definitive Healthcare operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 676 people. To learn more about Definitive Healthcare Corp call Kevin Coop at 508 720 4224 or check out https://www.definitivehc.com.

Definitive Healthcare Quarterly Total Revenue

62.29 Million

Definitive Healthcare Investment Alerts

Definitive Healthcare generated a negative expected return over the last 90 days
Definitive Healthcare has high historical volatility and very poor performance
The company generated the yearly revenue of 252.2 M. Annual Net Loss to common stockholders was (591.45 M) with gross profit of 211.52 M.
Over 95.0% of the company shares are held by institutions such as insurance companies
Latest headline from simplywall.st: Spotlight On 3 Penny Stocks With Market Caps Over 60M

Definitive Healthcare Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Definitive Healthcare previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
22nd of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Definitive Largest EPS Surprises

Earnings surprises can significantly impact Definitive Healthcare's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-02-26
2024-12-310.07180.080.008211 
2024-02-28
2023-12-310.080.07-0.0112 
2022-11-03
2022-09-300.050.060.0120 
View All Earnings Estimates

Definitive Healthcare Environmental, Social, and Governance (ESG) Scores

Definitive Healthcare's ESG score is a quantitative measure that evaluates Definitive Healthcare's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Definitive Healthcare's operations that may have significant financial implications and affect Definitive Healthcare's stock price as well as guide investors towards more socially responsible investments.

Definitive Healthcare Thematic Classifications

In addition to having Definitive Healthcare stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Health Management Idea
Health Management
Healthcare providers, hospitals
Data Storage Idea
Data Storage
Data Storage
Business Services Idea
Business Services
USA Equities from Business Services industry as classified by Fama & French

Definitive Stock Institutional Investors

Shares
Morgan Stanley - Brokerage Accounts2024-12-31
775.6 K
Millennium Management Llc2024-12-31
772.9 K
New York State Common Retirement Fund2024-12-31
771.8 K
D. E. Shaw & Co Lp2024-12-31
709.8 K
B. Riley Asset Management, Llc2024-12-31
677.9 K
Bank Of America Corp2024-12-31
617.5 K
Renaissance Technologies Corp2024-12-31
579.4 K
Citadel Advisors Llc2024-12-31
524.1 K
Northern Trust Corp2024-12-31
497.3 K
Advent International Lp2024-12-31
62.5 M
Irenic Capital Management Lp2024-12-31
M
Note, although Definitive Healthcare's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Definitive Market Capitalization

The company currently falls under 'Small-Cap' category with a market capitalization of 317.28 M.

Definitive Profitablity

The company has Net Profit Margin (PM) of (1.64) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.01 %, which signifies that for every $100 of sales, it has a net operating income of $0.01.
Last ReportedProjected for Next Year
Return On Tangible Assets(1.04)(0.99)
Return On Capital Employed(0.77)(0.73)
Return On Assets(0.38)(0.36)
Return On Equity(0.68)(0.65)

Management Efficiency

The Definitive Healthcare's current Return On Tangible Assets is estimated to increase to -0.99. The Definitive Healthcare's current Return On Capital Employed is estimated to increase to -0.73. As of now, Definitive Healthcare's Fixed Asset Turnover is decreasing as compared to previous years. The Definitive Healthcare's current Asset Turnover is estimated to increase to 0.24, while Net Tangible Assets are projected to decrease to (682 M). Definitive Healthcare's management efficiency ratios could be used to measure how well Definitive Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share 5.21  4.95 
Tangible Book Value Per Share(0.72)(0.76)
Enterprise Value Over EBITDA(0.68)(0.64)
Price Book Value Ratio 0.79  0.75 
Enterprise Value Multiple(0.68)(0.64)
Price Fair Value 0.79  0.75 
Enterprise Value384 M364.8 M
Examining the leadership quality of Definitive Healthcare Corp offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Operating Margin
0.0053
Profit Margin
(1.64)
Beta
1.514
Return On Assets
(0)
Return On Equity
(0.65)

Technical Drivers

As of the 25th of March, Definitive Healthcare shows the Mean Deviation of 3.2, standard deviation of 5.77, and Variance of 33.26. Definitive Healthcare technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Definitive Healthcare Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Definitive Healthcare middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Definitive Healthcare. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Definitive Healthcare Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Definitive Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Definitive Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Definitive Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
William Moschella 2 days ago
Disposition of 6711 shares by William Moschella of Definitive Healthcare at 4.41 subject to Rule 16b-3
 
Richard Booth over a week ago
Disposition of 963 shares by Richard Booth of Definitive Healthcare at 2.59 subject to Rule 16b-3
 
Winters Kathleen A over two weeks ago
Acquisition by Winters Kathleen A of 26759 shares of Definitive Healthcare subject to Rule 16b-3
 
Jason Krantz over a month ago
Disposition of 7471 shares by Jason Krantz of Definitive Healthcare at 5.55 subject to Rule 16b-3
 
Richard Booth over a month ago
Disposition of 27080 shares by Richard Booth of Definitive Healthcare at 4.86 subject to Rule 16b-3
 
William Moschella over two months ago
Disposition of 13421 shares by William Moschella of Definitive Healthcare at 4.11 subject to Rule 16b-3
 
Richard Booth over three months ago
Disposition of 1501 shares by Richard Booth of Definitive Healthcare at 4.49 subject to Rule 16b-3
 
William Moschella over three months ago
Disposition of 45000 shares by William Moschella of Definitive Healthcare at 4.7 subject to Rule 16b-3
 
Richard Booth over three months ago
Acquisition by Richard Booth of 92379 shares of Definitive Healthcare subject to Rule 16b-3
 
Jason Krantz over three months ago
Disposition of 7830 shares by Jason Krantz of Definitive Healthcare at 4.18 subject to Rule 16b-3
 
Jason Krantz over three months ago
Disposition of 2649 shares by Jason Krantz of Definitive Healthcare at 9.03 subject to Rule 16b-3
 
Shamsuddin Kate Marie over three months ago
Acquisition by Shamsuddin Kate Marie of 113379 shares of Definitive Healthcare subject to Rule 16b-3

Definitive Healthcare Outstanding Bonds

Definitive Healthcare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Definitive Healthcare uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Definitive bonds can be classified according to their maturity, which is the date when Definitive Healthcare Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Definitive Healthcare Predictive Daily Indicators

Definitive Healthcare intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Definitive Healthcare stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Definitive Healthcare Corporate Filings

F4
18th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F3
4th of March 2025
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
8K
27th of February 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
19th of February 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13th of February 2025
Other Reports
ViewVerify
F4
4th of February 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
16th of January 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
3rd of January 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Definitive Healthcare Forecast Models

Definitive Healthcare's time-series forecasting models are one of many Definitive Healthcare's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Definitive Healthcare's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Definitive Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Definitive Healthcare prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Definitive shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Definitive Healthcare. By using and applying Definitive Stock analysis, traders can create a robust methodology for identifying Definitive entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(2.51)(2.39)
Operating Profit Margin(2.82)(2.68)
Net Loss(1.64)(1.56)
Gross Profit Margin 0.78  0.58 

Current Definitive Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Definitive analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Definitive analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
5.25Buy14Odds
Definitive Healthcare Corp current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Definitive analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Definitive stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Definitive Healthcare, talking to its executives and customers, or listening to Definitive conference calls.
Definitive Analyst Advice Details

Definitive Stock Analysis Indicators

Definitive Healthcare Corp stock analysis indicators help investors evaluate how Definitive Healthcare stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Definitive Healthcare shares will generate the highest return on investment. By understating and applying Definitive Healthcare stock analysis, traders can identify Definitive Healthcare position entry and exit signals to maximize returns.
Begin Period Cash Flow131 M
Total Stockholder Equity607.2 M
Capital Lease Obligations10 M
Property Plant And Equipment Net11.3 M
Cash And Short Term Investments290.2 M
Net Invested Capital687.5 M
Cash105.4 M
50 Day M A4.174
Net Interest Income-245 K
Total Current Liabilities161.2 M
Forward Price Earnings13.3869
Investments-26.4 M
Interest Expense14.8 M
Stock Based Compensation38.1 M
Long Term Debt229.4 M
Common Stock Shares Outstanding116.6 M
Tax Provision-42.3 M
Free Cash Flow58.2 M
Other Current Assets26.8 M
Accounts Payable10.8 M
Net Debt-95.4 M
Other Operating Expenses963 M
Non Current Assets Total719.2 M
Liabilities And Stockholders Equity1.1 B
Non Currrent Assets Other16.7 M

Complementary Tools for Definitive Stock analysis

When running Definitive Healthcare's price analysis, check to measure Definitive Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Definitive Healthcare is operating at the current time. Most of Definitive Healthcare's value examination focuses on studying past and present price action to predict the probability of Definitive Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Definitive Healthcare's price. Additionally, you may evaluate how the addition of Definitive Healthcare to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bonds Directory
Find actively traded corporate debentures issued by US companies
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk